1,043 followers
RT @JoaquinJCabrera: Dose escalation for NSCLC. Why not this way? SBRT to the primary, standard fractionation to nodal disease. Small study…
307 followers
RT @JoaquinJCabrera: Dose escalation for NSCLC. Why not this way? SBRT to the primary, standard fractionation to nodal disease. Small study…
2,519 followers
RT @JoaquinJCabrera: Dose escalation for NSCLC. Why not this way? SBRT to the primary, standard fractionation to nodal disease. Small study…
2,712 followers
RT @JoaquinJCabrera: Dose escalation for NSCLC. Why not this way? SBRT to the primary, standard fractionation to nodal disease. Small study…
25 followers
RT @JoaquinJCabrera: Dose escalation for NSCLC. Why not this way? SBRT to the primary, standard fractionation to nodal disease. Small study…
267 followers
RT @JoaquinJCabrera: Dose escalation for NSCLC. Why not this way? SBRT to the primary, standard fractionation to nodal disease. Small study…
1,213 followers
RT @JoaquinJCabrera: Dose escalation for NSCLC. Why not this way? SBRT to the primary, standard fractionation to nodal disease. Small study…
63 followers
RT @JoaquinJCabrera: Dose escalation for NSCLC. Why not this way? SBRT to the primary, standard fractionation to nodal disease. Small study…
2,936 followers
"Concomitant boost" a lo bestia! Miedo a la toxicidad.
926 followers
RT @JoaquinJCabrera: Dose escalation for NSCLC. Why not this way? SBRT to the primary, standard fractionation to nodal disease. Small study…
1,956 followers
Dose escalation for NSCLC. Why not this way? SBRT to the primary, standard fractionation to nodal disease. Small study from South Korea. #sbrt #radonc #lcsm https://t.co/JZY1AoajDm
771 followers